alexa Metabolomic Profiling Reveals Potential Markers And Bioprocesses Altered In Bladder Cancer Progression
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Metabolomics & Systems Biology
March 24-26, 2014 Hilton San Antonio Airport, San Antonio, USA

Nagireddy Putluri
Accepted Abstracts: Metabolomics
DOI: 10.4172/2153-0769.S1.026
Abstract
Although alterations in xenobiotic metabolism are considered causal in the development of bladder cancer, theprecise mechanisms involved are poorly understood. In this study, we used high-throughput mass spectrometryto measure over 2,000 compounds in 58 clinical specimens, identifying 35 metabolites which exhibited significantchanges in bladder cancer. This metabolic signature distinguished both normal and benign bladder from bladdercancer. Exploratory analyses of this metabolomic signature in urine showed promise in distinguishing bladdercancer from controls and also nonmuscle from muscle-invasive bladder cancer. Subsequent enrichment-basedbioprocess mapping revealed alterations in phase I/ II metabolism and suggested a possible role for DNAmethylation in perturbing xenobiotic metabolism in bladder cancer. In particular, we validated tumor-associatedhypermethylation in the cytochrome P450 1A1 (CYP1A1) and cytochrome P450 1B1 (CYP1B1) promoters of bladdercancer tissues by bisulfite sequence analysis and methylation-specific PCR and also by in vitro treatment of T-24bladder cancer cell line with the DNA demethylating agent 5-aza-20-deoxycytidine. Furthermore, we showed thatexpression of CYP1A1 and CYP1B1 was reduced significantly in an independent cohort of bladder cancer specimenscompared with matched benign adjacent tissues. In summary, our findings identified candidate diagnostic andprognosticmarkers and highlightedmechanisms associatedwith the silencing of xenobioticmetabolism. Themetabolomicsignature we describe offers potential as a urinary biomarker for early detection and staging of bladdercancer, highlighting the utility of evaluating metabolomic profiles of cancer to gain insights into bioprocessesperturbed during tumor development and progression..
Biography
Nagireddy Putluri is the Director of the Cancer Metabolomics program at Baylor College of Medicine. Asst. Professor Nagireddy Putluri holds a doctorate in Analytical Chemistry (2007) and continued his education as Postdoctoral researcher at Medical College of Georgia (2009-2011) and Louisiana State University (2007-2009) before taking his position at Baylor College of Medicine. As the Director of the Metabolomics Program at the Alkek Center for Molecular Discovery, Baylor College of Medicine, he developed a highly reproducible, robust mass spectrometry platform that could measure more than >1000 metabolites from complex biological specimens. He successfully used this approach to study the metabolomic profiles associated with bladder cancer, a seminal study that was recently published in Cancer Research. Importantly, this paper was selected by the American Association for Cancer Research as a Research Highlight in 2011. His research also focused is in the area of prostate and breast cancer metabolomics. He published over 30 peer reviewed papers in this field and my research on small molecules mass spectrometry, peptides, bladder, prostate and breast cancer research.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords